Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.4B |
| 2 |
NVIDIA
NVDA
|
+$388M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$213M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Union Pacific
UNP
|
+$100M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$89.9M |
| 5 |
Marvell Technology
MRVL
|
+$89.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Industrials | 8.46% |
| 3 | Financials | 6.55% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Healthcare | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDL
1351
DELISTED
Avadel Pharmaceuticals
AVDL
| $558K | ﹤0.01% |
+25,905
| New | +$503K |
|
1352
Tenable Holdings
TENB
$3.65B
| $557K | ﹤0.01% |
23,664
-172,970
| -88% | -$4.73M |
|
|
YCY.U
1353
AA Mission Acquisition Corp II Units
YCY.U
| $556K | ﹤0.01% |
+55,140
| New | +$554K |
|
1354
Wabash National
WNC
$493M
| $553K | ﹤0.01% |
63,981
+46,565
| +267% | +$406K |
|
1355
TORM
TRMD
$3.26B
| $552K | ﹤0.01% |
28,177
+13,911
| +98% | +$294K |
|
1356
Corporacion America
CAAP
$3.97B
| $551K | ﹤0.01% |
+21,192
| New | +$475K |
|
|
SSEA
1357
Starry Sea Acquisition Corp
SSEA
$79M
| $551K | ﹤0.01% |
+54,979
| New | +$549K |
|
|
QUMS
1358
Quantumsphere Acquisition Corp
QUMS
| $551K | ﹤0.01% |
+55,000
| New | +$549K |
|
1359
Ascendis Pharma A/S
ASND
$16.6B
| $550K | ﹤0.01% |
2,581
-35,669
| -93% | -$7.37M |
|
1360
Coinbase
COIN
$49B
| $550K | ﹤0.01% |
2,432
-31,376
| -93% | -$9.35M |
|
1361
Hamilton Insurance Group
HG
$3.44B
| $549K | ﹤0.01% |
+19,692
| New | +$511K |
|
|
CEPF
1362
Cantor Equity Partners IV
CEPF
$593M
| $544K | ﹤0.01% |
52,919
+14,242
| +37% | +$148K |
|
1363
Qualcomm
QCOM
$168B
| $538K | ﹤0.01% |
3,147
-26,948
| -90% | -$4.62M |
|
|
CEPU
1364
Central Puerto
CEPU
$1.99B
| $537K | ﹤0.01% |
+30,713
| New | +$425K |
|
1365
dLocal
DLO
$4.46B
| $537K | ﹤0.01% |
37,957
-1,444
| -4% | -$20.4K |
|
1366
Essex Property Trust
ESS
$18.7B
| $537K | ﹤0.01% |
+2,051
| New | +$531K |
|
1367
Valmont Industries
VMI
$9.19B
| $533K | ﹤0.01% |
+1,324
| New | +$539K |
|
1368
Sarepta Therapeutics
SRPT
$1.98B
| $530K | ﹤0.01% |
24,620
+896
| +4% | +$18.9K |
|
1369
CALL
Boot Barn
BOOT
$4.88B
| $529K | ﹤0.01% |
+3,000
| New | +$560K |
|
|
1370
PUT
Boot Barn
BOOT
$4.88B
| $529K | ﹤0.01% |
+3,000
| New | +$560K |
|
1371
Genworth Financial
GNW
$3.71B
| $529K | ﹤0.01% |
58,609
+18,120
| +45% | +$158K |
|
1372
CALL
Ultragenyx Pharmaceutical
RARE
$2.58B
| $529K | ﹤0.01% |
+23,000
| New | +$756K |
|
1373
Rocket Pharmaceuticals
RCKT
$403M
| $524K | ﹤0.01% |
+149,413
| New | +$512K |
|
1374
Barings BDC
BBDC
$982M
| $523K | ﹤0.01% |
+57,012
| New | +$505K |
|
1375
Relay Therapeutics
RLAY
$4.47B
| $523K | ﹤0.01% |
+61,853
| New | +$441K |
|
Similar funds
Steve Schonfeld's Q4 2025 Portfolio in Review
As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.
- Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
- Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
- Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
- Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
- Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
- Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.